Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours. | Eur J Nucl Med Mol Imaging | 2004 | 2.45 |
2 | Multimodality registration without a dedicated multimodality scanner. | Mol Imaging | 2007 | 1.16 |
3 | Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management. | Cancer | 2003 | 0.89 |
4 | Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. | Oral Oncol | 2003 | 0.87 |
5 | Biodistribution and efficacy of [131I]A33scFv::CDy, a recombinant antibody-enzyme protein for colon cancer. | Int J Oncol | 2008 | 0.77 |